Chromatin modifications in immunoglobulin switch recombination

免疫球蛋白开关重组中的染色质修饰

基本信息

项目摘要

Switching to IgE can be activated by a combination of IL4, which induces transcription in that region, and activation of the cell surface CD40 receptor, which induces cell proliferation. Activation can be produced by anti-CD40 antibody or by a trimeric form of CD40 ligand.Our studies have focused on the human CL-01 line of B cells, which has been reported to undergo switch recombination. We have shown that IL4 causes a 100X increase in transcript, both unspliced and spliced, over the IgE switch region. We also observed a sizable (5X) increase in transcription of AID, the cytidine deaminase that is responsible for initiating CSR. A high resolution study of histone modifications in uninduced and induced CL-01 cells has been carried out, focusing on the region between the I-epsilon promoter and the 3 end of the IgE switch region, the most important region associated with this CSR event. The largest increases were found for acetyl-H3K9/14 (or acetyl-H3K9 alone) and for trimethyl-H3 K4, while other modifications including histone H4 tetra-acetylation (K5/8/12/16) and H3 K27 trimethylation were not greatly altered following IL4 induction. This pattern is consistent with broad activation of the region. Furthermore, the distribution of a given modification was in most cases non-uniform: for example, dimethyl-H3K4, tetraacetyl-H4, and acetyl-H3 K9/14 all showed relative peaks over the I-epsilon promoter. To interpret these results the abundance of nucleosomes was mapped across the same region, and a relative depletion over I-epsilon was observed, without any further change on induction. We are now extending these observations to studying the distribution of the histone variants H3.3 and H2A.Z. In addition we are studying DNA methylation in the same region. We have shown that treatment of the cells with 5-aza-deoxycytidine, a known demethylating agent, leads to an additional increase in IL4-stimulated transcription.
转换到IgE可以通过IL4和细胞表面CD40受体的结合来激活,IL4可以诱导该区域的转录,而CD40受体的激活可以诱导细胞增殖。激活可以通过抗CD40抗体或CD40配体的三聚体形式产生。我们的研究主要集中在人B细胞CL-01系,据报道,它经历了开关重组。我们已经证明,IL4在IgE开关区域导致转录物增加100倍,无论是未剪接的还是剪接的。我们还观察到,负责启动CSR的胞苷脱氨酶AID的转录显著增加(5倍)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARTIN F. GELLERT其他文献

MARTIN F. GELLERT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARTIN F. GELLERT', 18)}}的其他基金

Studies Of Immunoglobulin Gene Rearrangement
免疫球蛋白基因重排的研究
  • 批准号:
    7152479
  • 财政年份:
  • 资助金额:
    $ 41.97万
  • 项目类别:
Structural studies of the post-cleavage complex in V(D)J recombination
V(D)J 重组中裂解后复合物的结构研究
  • 批准号:
    7734112
  • 财政年份:
  • 资助金额:
    $ 41.97万
  • 项目类别:
Structural studies of sequential DNA cleavage by RAG1/RAG2 proteins in V(D)J recombination
V(D)J 重组中 RAG1/RAG2 蛋白连续 DNA 切割的结构研究
  • 批准号:
    9771218
  • 财政年份:
  • 资助金额:
    $ 41.97万
  • 项目类别:
Structural studies of proteins involved in V(D)J recombination
参与 V(D)J 重组的蛋白质的结构研究
  • 批准号:
    10697747
  • 财政年份:
  • 资助金额:
    $ 41.97万
  • 项目类别:
Studies Of Immunoglobulin Gene Rearrangement
免疫球蛋白基因重排的研究
  • 批准号:
    6664150
  • 财政年份:
  • 资助金额:
    $ 41.97万
  • 项目类别:
Structural studies of sequential DNA cleavage by RAG1/RAG2 proteins in V(D)J recombination
V(D)J 重组中 RAG1/RAG2 蛋白连续 DNA 切割的结构研究
  • 批准号:
    10000711
  • 财政年份:
  • 资助金额:
    $ 41.97万
  • 项目类别:
The post-cleavage complex in V(D)J recombination
V(D)J 重组中的裂解后复合物
  • 批准号:
    7593581
  • 财政年份:
  • 资助金额:
    $ 41.97万
  • 项目类别:
Nonheritable Antibiotic Resistance
非遗传性抗生素耐药性
  • 批准号:
    7593539
  • 财政年份:
  • 资助金额:
    $ 41.97万
  • 项目类别:
Chromatin modifications in immunoglobulin switch recombination
免疫球蛋白开关重组中的染色质修饰
  • 批准号:
    8148771
  • 财政年份:
  • 资助金额:
    $ 41.97万
  • 项目类别:
Chromatin modifications in immunoglobulin switch recombination
免疫球蛋白开关重组中的染色质修饰
  • 批准号:
    7967408
  • 财政年份:
  • 资助金额:
    $ 41.97万
  • 项目类别:

相似海外基金

Development of therapeutic monoclonal antibodies aiming at an application and the immunosuppression to an allergic disease of Fingolimod
针对芬戈莫德过敏性疾病的应用和免疫抑制的治疗性单克隆抗体的开发
  • 批准号:
    16K08409
  • 财政年份:
    2016
  • 资助金额:
    $ 41.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Prevention of Allergic Rhinitis with Topical Immunomodulating Antibodies
使用外用免疫调节抗体预防过敏性鼻炎
  • 批准号:
    8201881
  • 财政年份:
    2011
  • 资助金额:
    $ 41.97万
  • 项目类别:
Development of antibodies to Il-13 receptor and their preclinical testing in a sheep model for human allergic asthma
IL-13受体抗体的开发及其在人类过敏性哮喘绵羊模型中的临床前测试
  • 批准号:
    nhmrc : 310603
  • 财政年份:
    2004
  • 资助金额:
    $ 41.97万
  • 项目类别:
    Early Career Fellowships
B-1 B cells as a source of polyreactive IgE antibodies, in allergic individuals
B-1 B 细胞作为过敏个体中多反应性 IgE 抗体的来源
  • 批准号:
    nhmrc : 209590
  • 财政年份:
    2002
  • 资助金额:
    $ 41.97万
  • 项目类别:
    NHMRC Project Grants
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
哺乳动物寡糖半乳糖-α-1, 3-半乳糖 (α-gal) 的 IgE 抗体:免疫学、流行病学以及与过敏性和炎症性疾病的相关性
  • 批准号:
    10518418
  • 财政年份:
    1984
  • 资助金额:
    $ 41.97万
  • 项目类别:
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
哺乳动物寡糖半乳糖-α-1, 3-半乳糖 (α-gal) 的 IgE 抗体:免疫学、流行病学以及与过敏性和炎症性疾病的相关性
  • 批准号:
    10119751
  • 财政年份:
    1984
  • 资助金额:
    $ 41.97万
  • 项目类别:
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
哺乳动物寡糖半乳糖-α-1, 3-半乳糖 (α-gal) 的 IgE 抗体:免疫学、流行病学以及与过敏性和炎症性疾病的相关性
  • 批准号:
    10425338
  • 财政年份:
    1984
  • 资助金额:
    $ 41.97万
  • 项目类别:
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
哺乳动物寡糖半乳糖-α-1, 3-半乳糖 (α-gal) 的 IgE 抗体:免疫学、流行病学以及与过敏性和炎症性疾病的相关性
  • 批准号:
    10190780
  • 财政年份:
    1984
  • 资助金额:
    $ 41.97万
  • 项目类别:
MONOCLONAL ANTIBODIES FROM ALLERGIC PATIENTS
来自过敏患者的单克隆抗体
  • 批准号:
    3960798
  • 财政年份:
  • 资助金额:
    $ 41.97万
  • 项目类别:
MONOCLONAL ANTIBODIES FROM ALLERGIC PATIENTS
来自过敏患者的单克隆抗体
  • 批准号:
    4688732
  • 财政年份:
  • 资助金额:
    $ 41.97万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了